MIA leads world-class skin tumour pathology conference
14 February 2020
World-leading skin cancer experts, headed by Co-Medical Director of Melanoma Institute Australia Professor Richard Scolyer, will converge on The University of Sydney’s Charles Perkins Centre this weekend to instruct a sold-out, two-day course on ‘Pigmented Lesions and Other Hot Topics in Dermatopathology’.
Attendees will also hear from two international melanoma experts across the breadth of the program - Professor Klaus Busam, Director of Dermatopathology at Memorial Sloan Kettering Cancer Centre, New York, and Professor Pedram Gerami, Professor of Dermatology at Northwestern University, Illinois.
MIA clinicians and researchers will provide a wealth of home-grown expertise with talks from epidemiologist Professor Anne Cust, pathologists Dr Peter Ferguson and Dr Robert Rawson, world-renowned melanoma and surgical oncologist Professor John Thompson, and Co-Medical Director of MIA Professor Georgina Long.
The course aims to provide international attendees with the latest in skin tumour pathology, discussing current best practice and new tests, along with highlighting the integration of clinical and genomic information for diagnosis, prognosis and treatment selection. The course will end with detailed examination of high-value educational cases to consolidate two days worth of world-class learnings.
Former Executive Director of Melanoma Institute Australia Professor John Thompson awarded the prestigious 2018 RPA Foundation Research Medal.
Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for pembrolizumab.
The World Congress on Cancers of the Skin 2018 has featured many minds from MIA sharing their expertise and wealth of knowledge with over 1000 attendees from around the world.
Melanoma Institute Australia is delighted to announce the appointment of Matthew Browne as Chief Executive Officer (CEO).
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.